LGC custom oligonucleotides used to develop innovative arboviruses diagnostic kit

News (ZH) - Innovative kit,  recently registered with the National Health Surveillance Agency, can screen for differentiation in the same reaction on the type of dengue (1, 2, 3 or 4)

LGC expedites access to its core technology to support a rapid response to the coronavirus global health emergency

News (ZH) - Supporting efforts to contain virus by expediting availability of mission-critical oligo chemistries, controls and components

LGC and customers expediting coronavirus diagnostic solutions

News (ZH) - Working closely with customers to ensure mission-critical oligo chemistries, controls and components for detection kits are available where and when necessary

LGC, Biosearch Technologies detection reagents approved by CDC for COVID-19 diagnosis

News (ZH) - Testing labs can purchase approved kits from CDC-qualified lot 143503 as of today

LGC expedites support to COVID-19 response efforts

News (ZH) - LGC is working closely with customers and other stakeholders to support the global response to the epidemic

LGC working closely with customers and partners to expedite detection solutions

News (ZH) - Working together on supply of a SARS-CoV-2 assay for laboratory use which delivers a result in approximately 70 minutes

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News (ZH) - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

LGC releases SARS-CoV-2 & influenza multiplexed molecular quality solutions

News (ZH) - Kit designed to measure day-to-day performance of the assay providing positive and negative reference solution